News & Blog

Immunitas Therapeutics to Present Preclinical Data on IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies

BioCentury: Medical Excellence to fund cell, gene therapy, AI and regenerative medicine with $145M debut fund

Wall Street Journal: Life Sciences Venture Investor MEC Raises $145 Million Fund

Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund

Cell Therapy in CNS: Why now?

Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer

Multi-omics Startup Pleno Inc. Announces $15 Million in Pre-Series A Funding

ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO

Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners